Kristin Berry

5.4k total citations · 3 hit papers
78 papers, 3.6k citations indexed

About

Kristin Berry is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Kristin Berry has authored 78 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 40 papers in Hepatology and 21 papers in Oncology. Recurrent topics in Kristin Berry's work include Liver Disease Diagnosis and Treatment (35 papers), Hepatitis C virus research (22 papers) and Liver Disease and Transplantation (21 papers). Kristin Berry is often cited by papers focused on Liver Disease Diagnosis and Treatment (35 papers), Hepatitis C virus research (22 papers) and Liver Disease and Transplantation (21 papers). Kristin Berry collaborates with scholars based in United States, Australia and South Africa. Kristin Berry's co-authors include George N. Ioannou, Pamela K. Green, Pamela Green, Lauren A. Beste, Scott D. Ramsey, Feng Su, Emily R. Locke, Ruth Etzioni, Kathleen F. Kerr and Elliott Lowy and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Kristin Berry

77 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma

2017 386 citations George N. Ioannou, Pamela K. Green et al. Journal of Hepatology profile →
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores

2019 233 citations George N. Ioannou, Lauren A. Beste et al. Gastroenterology profile →
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study

2025 13 citations Kristina L. Bajema, Lei Yan et al. profile →

Peers

Countries citing papers authored by Kristin Berry

Since Specialization

Citations

This map shows the geographic impact of Kristin Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristin Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristin Berry more than expected).

Fields of papers citing papers by Kristin Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristin Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristin Berry. The network helps show where Kristin Berry may publish in the future.

Co-authorship network of co-authors of Kristin Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Kristin Berry. A scholar is included among the top collaborators of Kristin Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristin Berry. Kristin Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up 2025 ·Annals of Internal Medicine ·George N. Ioannou, Kristin Berry, Nallakkandi Rajeevan, Yuli Li, Lei Yan, Yuan Huang, Hung‐Mo Lin, David Bui, Denise M. Hynes, Mazhgan Rowneki, Amy S. B. Bohnert, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Valerie A. Smith, Theodore S. Z. Berkowitz, Ann M. O’Hare, Elizabeth M. Viglianti, Mihaela Aslan, Kristina L. Bajema	4
2	Exposure to outdoor air pollution, wildfires, and cancer survival in the United States 2025 ·Cancer Epidemiology ·Trang VoPham, Tianjia Liu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stephanie D. Chao, (unknown), Boris Quennehen, Jason A. Mendoza, George N. Ioannou, Kristin Berry, Gary Adamkiewicz, Christopher I. Li, Jaime E. Hart	1
3	Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening 2025 ·Gastroenterology ·Nicole J. Kim, Muyi Li, Philip Vutien, Brig Mecham, Joleen Borgerding, (unknown), (unknown), (unknown), (unknown), Catherine Mezzacappa, Kristin Berry, Trang VoPham, Tracey L. Marsh, Ziding Feng, Kay M. Johnson, Lauren A. Beste, David E. Kaplan, Tamar H. Taddei, George N. Ioannou	1
4	Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death 2024 ·Hepatology ·Philip Vutien, (unknown), Nicole J. Kim, Andrew M. Moon, Chun‐Nan Hsu, Catherine Mezzacappa, Joleen Borgerding, Kay M. Johnson, Trang VoPham, Kristin Berry, (unknown), David E. Kaplan, Tamar H. Taddei, George N. Ioannou	4
5	Rates of and Factors Associated With Primary and Booster COVID-19 Vaccine Receipt by US Veterans, December 2020 to June 2022 2023 ·JAMA Network Open ·Kristina L. Bajema, Mazhgan Rowneki, Kristin Berry, Amy S. B. Bohnert, C. Barrett Bowling, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Ann M. O’Hare, Thomas F. Osborne, Elizabeth M. Viglianti, Denise M. Hynes, George N. Ioannou	10
6	Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans 2023 ·Annals of Internal Medicine ·George N. Ioannou, Kristin Berry, Nallakkandi Rajeevan, Yuli Li, (unknown), Lei Yan, David Bui, Francesca Cunningham, Denise M. Hynes, Mazhgan Rowneki, Amy S. B. Bohnert, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Thomas F. Osborne, Elizabeth M. Viglianti, Mihaela Aslan, Grant D. Huang, Kristina L. Bajema	26
7	Anti–SARS-CoV-2 Pharmacotherapies Among Nonhospitalized US Veterans, January 2022 to January 2023 2023 ·JAMA Network Open ·Lei Yan, Elani Streja, Yuli Li, Nallakkandi Rajeevan, Mazhgan Rowneki, Kristin Berry, Denise M. Hynes, Francesca Cunningham, Grant D. Huang, Mihaela Aslan, George N. Ioannou, Kristina L. Bajema	9
8	Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era 2022 ·Annals of Internal Medicine ·George N. Ioannou, Amy S. B. Bohnert, Ann M. O’Hare, Edward J. Boyko, Matthew L. Maciejewski, Valerie A. Smith, C. Barrett Bowling, Elizabeth M. Viglianti, Theodore J. Iwashyna, Denise M. Hynes, Kristin Berry, Pamela Green, Alexandra Fox, Anna Korpak, Troy A. Shahoumian, Alex Hickok, Mazhgan Rowneki, Xiao Qing Wang, Emily R. Locke	29
9	PM2.5 air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample 2022 ·Environmental Research ·Trang VoPham, Nicole J. Kim, Kristin Berry, Jason A. Mendoza, Joel D. Kaufman, George N. Ioannou	56
10	Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system 2022 ·EClinicalMedicine ·George N. Ioannou, Emily R. Locke, Pamela K. Green, Kristin Berry	27
11	Trends Over Time in the Risk of Adverse Outcomes Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection 2021 ·Clinical Infectious Diseases ·George N. Ioannou, Ann M. O’Hare, Kristin Berry, Vincent S. Fan, Kristina Crothers, McKenna C. Eastment, Emily R. Locke, Pamela Green, Javeed A. Shah, Jason A. Dominitz	11
12	Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study 2021 ·PLoS Medicine ·George N. Ioannou, Jacqueline M. Ferguson, Ann M. O’Hare, Amy S. B. Bohnert, Lisa I. Backus, Edward J. Boyko, Thomas F. Osborne, Matthew L. Maciejewski, C. Barrett Bowling, Denise M. Hynes, Theodore J. Iwashyna, (unknown), Pamela Green, Kristin Berry	14
13	Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification 2019 ·Journal of Hepatology ·George N. Ioannou, Pamela Green, Kathleen F. Kerr, Kristin Berry	138
14	HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma breakdown → 2017 ·Journal of Hepatology ·George N. Ioannou, Pamela K. Green, Kristin Berry	386
15	Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences 2016 ·Journal of the American College of Radiology ·Christoph I. Lee, Mark Bensink, Kristin Berry, (unknown), (unknown), Robert Dann, Jeffrey G. Jarvik, Constance D. Lehman, Scott D. Ramsey	4
16	Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit 2015 ·Gastroenterology ·Feng Su, Lei Yu, Kristin Berry, Iris Liou, Charles Landis, Stephen C. Rayhill, Jorgé Reyes, George N. Ioannou	142
17	ECONOMIC EVALUATION OF DIAGNOSTIC LOCALIZATION FOLLOWING BIOCHEMICAL PROSTATE CANCER RECURRENCE 2014 ·International Journal of Technology Assessment in Health Care ·Daniel A. Barocas, Mark Bensink, Kristin Berry, (unknown), (unknown), (unknown), Scott D. Ramsey	3
18	Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences 2013 ·Journal of the American College of Radiology ·Christoph I. Lee, Mark Bensink, Kristin Berry, (unknown), (unknown), Robert Dann, Jeffrey G. Jarvik, Constance D. Lehman, Scott D. Ramsey	6
19	Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma 2013 ·Liver Transplantation ·Kristin Berry, George N. Ioannou	117
20	Are Patients with Child’s A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation? 2011 ·American Journal of Transplantation ·Kristin Berry, George N. Ioannou	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact